Rituximab induces sustained reduction of pathogenic B cells in patients with 
peripheral nervous system autoimmunity

Maurer, Michael A.; Rakocevic, Goran; Leung, Carol S.; Quast, Isaak; Lukacisin, Martin; Goebels, Norbert; Münz, Christian; Wardemann, Hedda; Dalakas, Marinos; Lünemann, Jan D.

doi:10.1172/JCI58743

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

Rituximab induces sustained reduction of pathogenic B cells in patients with peripheral nervous system autoimmunity

MPS-Authors

/persons/resource/persons82204

Wardemann, Hedda
Max-Planck Research Group Molecular Immunology, Max Planck Institute for Infection Biology, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

J_Clin_Invest_2012_122_1393.pdf
(Publisher version), 2MB

Supplementary Material (public)

There is no public supplementary material available

Citation

Maurer, M. A., Rakocevic, G., Leung, C. S., Quast, I., Lukacisin, M., Goebels, N., et al. (2012). Rituximab induces sustained reduction of pathogenic B cells in patients with peripheral nervous system autoimmunity. JOURNAL OF CLINICAL INVESTIGATION, 122(4), 1393-1402. doi:10.1172/JCI58743.

Cite as: https://hdl.handle.net/11858/00-001M-0000-000E-BE0C-E

Abstract

There is no abstract available